PDCD1 and neoplasm: For instance, when co-expressed with TIM-3, PD-1 decreases the secretion of various pro-inflammatory cytokines, such as IL-2, IFN-γ, and TNF, and results in T cell tolerance towards tumor cells in acute myelogenous leukemia, colon adenocarcinoma, and melanoma [43,44,45].